| top | |
| GLIOBLASTOMA NEWSLETTER | |
Volume 1, Number 1 - 29 July 2002 |
|
|
|
|
|
Contents |
|
|
|
|
| Diagnosis & Evaluation | |
| Etiology & Pathogenesis | |
| Psychosocial Aspects | |
| Treatment | |
|
|
|
|
|
|
|
|
|
|
Shaan M. Raza, B.S.; Frederick F. Lang, M.D.; Bharat B.
Aggarwal, Ph.D.; Gregory N. Fuller, Ph.D., M.D.; David M. Wildrick, Ph.D.; Raymond
Sawaya,M.D. Necrosis and Glioblastoma: A Friend or a Foe? A Review and a Hypothesis Neurosurgery. 51(1):2-13, July 2002 
Abstract
| 
DBLinks | BL 1:1
|
|
|
|
|
|
|
|
|
|
|
|
Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors
LB, Cobbs CG, Britt WJ. Human cytomegalovirus infection and expression in human malignant glioma Cancer Res. 2002 Jun 15;62(12):3347-50
Abstract |
Full Text |
Reprint |
DBLinks | BL 1:1
|
|
|
Fulci G, Ishii N, Maurici D, Gernert KM, Hainaut P,
Kaur B, Van Meir EG. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion Cancer Res. 2002 May 15;62(10):2897-905
Abstract |
Full Text |
Reprint |
DBLinks | BL 1:1
|
|
|
Maluf FC, DeAngelis LM, Raizer JJ, Abrey LE. High-grade gliomas in patients with prior systemic malignancies Cancer. 2002 Jun 15;94(12):3219-24
Abstract |
Full Text |
Reprint |
DBLinks | BL 1:1
|
|
|
McNally RJ, Cairns DP, Eden OB, Alexander FE, Taylor
GM, Kelsey AM, Birch JM. An infectious aetiology for childhood brain tumours? Evidence from space-time clustering and seasonality analyses Br J Cancer. 2002 Apr 8;86(7):1070-7
Abstract |
DBLinks | BL 1:1 |
|
|
Shiraishi S, Tada K, Nakamura H, Makino K, Kochi M,
Saya H, Kuratsu J, Ushio Y. Influence of p53 mutations on prognosis of patients with glioblastoma Cancer. 2002 Jul 11;95(2):249-57
Abstract |
Full Text |
Reprint |
DBLinks | BL 1:1 |
|
|
|
|
|
|
|
|
|
|
|
Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues J Neurooncol. 2002 Mar;57(1):41-9
Abstract |
Reprint |
DBLinks | BL 1:1 |
|
|
|
|
|
|
|
|
|
|
|
J A Glaspy, J S Jadeja, G Justice, J Kessler, D
Richards, L Schwartzberg, NS Tchekmedyian, S Armstrong, J O'Byrne, G Rossi and A B Colowick Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated withcancer chemotherapy British Journal of Cancer, 29 July 2002, Volume 87, Number 3, Pages 268-276
Abstract |
DBLinks | BL 1:1
|
|
|
Kleinberg L, Grossman SA, Carson K, Lesser G, O'Neill
A, Pearlman J,Phillips P, Herman T, Gerber M. Survival of Patients With Newly Diagnosed Glioblastoma Multiforme Treated With RSR13 and Radiotherapy: Results of a Phase II New Approaches to Brain Tumor Therapy CNS Consortium Safety and Efficacy Study J Clin Oncol. 2002 Jul 15;20(14):3149-55
Abstract |
Full Text |
Reprint |
DBLinks | BL 1:1 |
|
|
Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK,
Seyfried TN. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model Br J Cancer. 2002 May 20;86(10):1615-21
Abstract |
DBLinks | BL 1:1 |
|
|
Surasak Phuphanich Recurrent Multicentric Glioblastoma Multiforme Responds to Thalidomide and Chemotherapy Oncology, Vol 16, No 3 (March 2002), Letter to the Editor
Abstract |
Full Text |
Reprint |
DBLinks | BL 1:1 |
|
|
Trent S, Kong A, Short SC, Traish D, Ashley S, Dowe A,
Hines F, Brada M. Temozolomide as second-line chemotherapy for relapsed gliomas J Neurooncol. 2002 May;57(3):247-51
Abstract |
Reprint |
DBLinks | BL 1:1 |
|
